GSK PLC 2022 SR
The report highlights GSK's transition to a fully-focused biopharma company following the demerger of its Consumer Healthcare business. Key achievements in 2022 include reaching 73 million people in lower-income countries with products and progressing 12 Global Health pipeline assets for priority diseases. The company achieved a 6% reduction in Scope 1 and 2 emissions and a 13% reduction in Scope 3 emissions from 2020 to 2021. GSK also met its 2030 target of reducing water use by 20% ahead of schedule. Furthermore, the company improved leadership diversity, with women holding 42% of VP-and-above roles globally.
Company: GSK PLC
Sector: Health Care
Country: United Kingdom
Year: 2022
Type: SR
Pages: 55
GSK PLC
ESG Performance Report
The report highlights GSK's transition to a fully-focused biopharma company following the demerger of its Consumer Healthcare business. Key achievements in 2022 include reaching 73 million people in lower-income countries with products and progressing 12 Global Health pipeline assets for priority diseases. The company achieved a 6% reduction in Scope 1 and 2 emissions and a 13% reduction in Scope 3 emissions from 2020 to 2021. GSK also met its 2030 target of reducing water use by 20% ahead of schedule. Furthermore, the company improved leadership diversity, with women holding 42% of VP-and-above roles globally.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Mar 3, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees